68th Day Of Lockdown

Maharashtra65168280812197 Tamil Nadu2024611313157 Delhi173877846398 Gujarat1635692321007 Rajasthan83654855184 Madhya Pradesh78914444343 Uttar Pradesh77014651213 West Bengal48131775302 Andhra Pradesh3461228960 Bihar3359120915 Karnataka292299749 Telangana2499141277 Jammu and Kashmir234190828 Punjab2197194942 Odisha17239779 Haryana172194019 Kerala120957510 Assam9361044 Uttarakhand493794 Jharkhand4621914 Chhatisgarh4471021 Chandigarh2891994 Tripura2711720 Himachal Pradesh223634 Goa70420 Manipur6060 Puducherry57230 Nagaland3600 Meghalaya27121 Arunachal Pradesh310 Mizoram110 Sikkim100
Business Other News 25 Mar 2020 India bans export of ...

India bans export of key malaria drug amid coronavirus outbreak

REUTERS
Published Mar 25, 2020, 2:15 pm IST
Updated Mar 25, 2020, 5:59 pm IST
Experts test the efficacy of the drug in helping treat patients infected with COVID-19
Representative Image (Biospace)
 Representative Image (Biospace)

NEW DELHI: The Indian government said on Wednesday that it is banning the export of hydroxychloroquine and formulations made from the medication, as experts test the efficacy of the drug in helping treat patients infected with COVID-19.

There are currently no approved treatments, or preventive vaccines for COVID-19, the highly contagious, sometimes deadly respiratory illness caused by the new coronavirus.

 

Researchers are studying existing treatments and working on experimental ones, but most current patients receive only supportive care such as breathing assistance.

Hydroxychloroquine, a malaria drug, is among the medications that are being tested, as a potential treatment for patients with the disease. Earlier this week, the American Society of Health-System Pharmacists (ASHP), which maintains a list of drug shortages, said hydroxychloroquine was in shortage.

“Chloroquine has demonstrated toxicity in certain patients,” Dinesh Dua, chairman of the Pharmaceuticals Export Promotion Council of India, said. “You have to tread with caution because there is no comprehensive data to prove it works.”

The group said India faced no shortages of the drug but they warned companies were facing acute shortages of staff to run operations.

Late on Tuesday, India ordered a 21-day lockdown of its 1.3 billion people to try to protect the world’s second most populous country from the fast-spreading coronavirus.

“It is impossible to maintain operations due to lockdown, because employees don’t want to come,” Dua said.

India has already banned export of all ventilators and sanitizers and personal protection equipment such as masks and clothing to contain the outbreak that has so far infected more than 550 people and claimed close to a dozen lives in the country.

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT